Perrier, R., A. Pirog, M. Jaffredo, J. Gaitan, B. Catargi, S. Renaud, M. Raoux, and J. Lang. Bioelectronic organ-based sensor for microfluidic real-time analysis of the demand in insulin. Biosensors and Bioelectronics, 2018. 117, 253-259.
Schlumberger,
M., S. Leboulleux, B. Catargi, D. Deandreis, S. Zerdoud, S. Bardet, D. Rusu, Y.
Godbert, C. Buffet, C. Schvartz, P. Vera, O. Morel, D. Benisvy, C. Bournaud,
M.E. Toubert, A. Kelly, E. Benhamou, and I. Borget (2018) Outcome after
ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up
results of a randomised, phase 3, equivalence trial. Lancet Diabetes
Endocrinol: PMID 29807824
Jeandidier, N., L. Chaillous, S. Franc, P.Y. Benhamou, P. Schaepelynck, H. Hanaire, B. Catargi, A. Farret, P. Fontaine, B. Guerci, Y. Reznik, A. Penfornis, S. Borot, P. Serusclat, Y. Kherbachi, G. D'Orsay, B. Detournay, P. Simon, and G. Charpentier (2018) DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial. JMIR Res Protoc, 7: p. e66.
Cosson, E., B. Catargi, G. Cheisson, S.
Jacqueminet, C. Ichai, A.M. Leguerrier, A. Ouattara, I. Tauveron, E. Bismuth,
D. Benhamou, and P. Valensi (2018) Practical management of diabetes patients
before, during and after surgery: A joint French diabetology and
anaesthesiology position statement. Diabetes Metab, 44: p. 200-216.
Borot, S., P.Y. Benhamou, C. Atlan, E. Bismuth, E. Bonnemaison, B.
Catargi, G. Charpentier, A. Farret, N. Filhol, S. Franc, D. Gouet, B. Guerci,
I. Guilhem, C. Guillot, N. Jeandidier, M. Joubert, V. Melki, E. Merlen, A.
Penfornis, S. Picard, E. Renard, Y. Reznik, J.P. Riveline, S. Rudoni, P.
Schaepelynck, A. Sola-Gazagnes, N. Tubiana-Rufi, O. Verier-Mine, and H. Hanaire
(2018) Practical implementation, education and interpretation guidelines for
continuous glucose monitoring: A French position statement. Diabetes Metab, 44:
p. 61-72.
A. Ravaud, C. de la Fouchardiere,
P. Caron, A. Doussau, C. Do Cao, J. Asselineau, P. Rodien, D. Pouessel, P.
Nicolli-Sire, M. Klein, C. Bournaud-Salinas, J.L. Wemeau, A. Gimbert, M.Q.
Picat, D. Pedenon, L. Digue, A. Daste, B. Catargi, J.P. Delord, A multicenter
phase II study of sunitinib in patients with locally advanced or metastatic
differentiated, anaplastic or medullary thyroid carcinomas: mature data from
the THYSU study, Eur J Cancer, 76 (2017) 110-117.
B.
Neal, V. Perkovic, K.W. Mahaffey, D. de Zeeuw, G. Fulcher, N. Erondu, W. Shaw,
G. Law, M. Desai, D.R. Matthews, Canagliflozin and Cardiovascular and Renal
Events in Type 2 Diabetes, N Engl J Med, 377 (2017) 644-657.
D.
Taieb, C. Bournaud, M.C. Eberle, B. Catargi, C. Schvartz, M.B. Cavarec, I.
Faugeron, M.E. Toubert, D. Benisvy, C. Archange, O. Mundler, P. Caron, A.E.
Abdullah, K. Baumstarck, Quality of life, clinical outcomes and safety of early
prophylactic levothyroxine administration in patients with Graves'
hyperthyroidism undergoing radioiodine therapy: a randomized controlled study,
Eur J Endocrinol, 174 (2016) 491-502.
S.
Lassalle, J. Zangari, A. Popa, M. Ilie, V. Hofman, E. Long, M. Patey, F.
Tissier, G. Belleannee, H. Trouette, B. Catargi, I. Peyrottes, J.L. Sadoul, O.
Bordone, C. Bonnetaud, C. Butori, A. Bozec, N. Guevara, J. Santini, I.S.
Henaoui, G. Lemaire, O. Blanck, P. Vielh, P. Barbry, B. Mari, P. Brest, P.
Hofman, MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of
vandetanib, Oncotarget, 7 (2016) 30461-30478.
S.
Denisov, F. Pinaud, M. Chambaud, V. Lapeyre, B. Catargi, N. Sojic, N.
McClenaghan, V. Ravaine, Saccharide-induced modulation of photoluminescence
lifetime in microgels, Physical Chemistry Chemical Physics, 18 (2016)
16812-16821.
Verges,
B. Patois-Verges, M.C. Iliou, I. Simoneau-Robin, J.H. Bertrand, J.M. Feige, H.
Douard, B. Catargi, M. Fischbach, Influence of glycemic control on gain in VO2
peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after
an acute coronary syndrome. The prospective DARE study, BMC Cardiovasc Disord,
15 (2015) 64.
F.
Pinaud, R. Millereux, P. Vialar-Trarieux, B. Catargi, S. Pinet, I. Gosse, N.
Sojic, V. Ravaine, Differential Photoluminescent and Electrochemiluminescent
Behavior for Resonance Energy Transfer Processes in Thermoresponsive Microgels,
J Phys Chem B, 119 (2015) 12954-12961.
M.A.
Pfeffer, B. Claggett, R. Diaz, K. Dickstein, H.C. Gerstein, L.V. Kober, F.C.
Lawson, L. Ping, X. Wei, E.F. Lewis, A.P. Maggioni, J.J. McMurray, J.L.
Probstfield, M.C. Riddle, S.D. Solomon, J.C. Tardif, Lixisenatide in Patients
with Type 2 Diabetes and Acute Coronary Syndrome, N Engl J Med, 373 (2015)
2247-2257.
F.
Lebreton, A. Pirog, I. Belouah, D. Bosco, T. Berney, P. Meda, Y. Bornat, B.
Catargi, S. Renaud, M. Raoux, Slow potentials encode intercellular coupling and
insulin demand in pancreatic beta cells, Diabetologia, 58 (2015) 1291-1299.
M.
Joubert, S. Baillot-Rudoni, B. Catargi, G. Charpentier, A. Esvant, S. Franc, B.
Guerci, I. Guilhem, V. Melki, E. Merlen, Indication, organization, practical
implementation and interpretation guidelines for retrospective CGM recording: A
French position statement, Diabetes & metabolism, 41 (2015) 498-508.
I.
Borget, J. Bonastre, B. Catargi, D. Déandréis, S. Zerdoud, D. Rusu, S. Bardet,
L. Leenhardt, D. Bastie, C. Schvartz, Quality of life and cost-effectiveness
assessment of radioiodine ablation strategies in patients with thyroid cancer:
results from the randomized phase III ESTIMABL trial, Journal of Clinical
Oncology, 33 (2015) 2885-2892.
D.
Tarus, E. Hachet, L. Messager, B. Catargi, V. Ravaine, R. Auzély‐Velty, Readily
Prepared Dynamic Hydrogels by Combining Phenyl Boronic Acid‐and
Maltose‐Modified Anionic Polysaccharides at Neutral pH, Macromolecular rapid
communications, 35 (2014) 2089-2095.
P.
Schaepelynck, J.-P. Riveline, E. Renard, H. Hanaire, B. Guerci, S.
Baillot-Rudoni, A. Sola-Gazagnes, B. Catargi, P. Fontaine, L. Millot,
Assessment of a new insulin preparation for implanted pumps used in the
treatment of type 1 diabetes, Diabetes technology & therapeutics, 16 (2014)
582-589.
S.
Renaud, B. Catargi, J. Lang, Biosensors in Diabetes: How to get the most out of
evolution and transpose it into a signal, IEEE pulse, 5 (2014) 30-34.
F.
Pinaud, K. Geisel, P. Massé, B. Catargi, L. Isa, W. Richtering, V. Ravaine, V.
Schmitt, Adsorption of microgels at an oil–water interface: correlation between
packing and 2D elasticity, Soft Matter, 10 (2014) 6963-6974.
L.
Messager, N. Portecop, E. Hachet, V. Lapeyre, I. Pignot-Paintrand, B. Catargi,
R. Auzély-Velty, V. Ravaine, Photochemical crosslinking of hyaluronic acid
confined in nanoemulsions: towards nanogels with a controlled structure,
Journal of Materials Chemistry B, 1 (2013) 3369-3379.
B.
Verges, A. Avignon, F. Bonnet, B. Catargi, S. Cattan, E. Cosson, G. Ducrocq, M.
Elbaz, A. Fredenrich, P. Gourdy, Consensus statement on the care of the
hyperglycaemic/diabetic patient during and in the immediate follow-up of acute
coronary syndrome, Diabetes & metabolism, 38 (2012) 113-127.
M.
Schlumberger, B. Catargi, I. Borget, D. Deandreis, S. Zerdoud, B. Bridji, S.
Bardet, L. Leenhardt, D. Bastie, C. Schvartz, P. Vera, O. Morel, D. Benisvy, C.
Bournaud, F. Bonichon, C. Dejax, M.E. Toubert, S. Leboulleux, M. Ricard, E.
Benhamou, Strategies of radioiodine ablation in patients with low-risk thyroid
cancer, N Engl J Med, 366 (2012) 1663-1673.
J.-P.
Riveline, P. Schaepelynck, L. Chaillous, E. Renard, A. Sola-Gazagnes, A.
Penfornis, N. Tubiana-Rufi, V. Sulmont, B. Catargi, C. Lukas, Assessment of
patient-led or physician-driven continuous glucose monitoring in patients with
poorly controlled type 1 diabetes using basal-bolus insulin regimens, Diabetes
Care, 35 (2012) 965-971.
M.
Raoux, Y. Bornat, A. Quotb, B. Catargi, S. Renaud, J. Lang, Non‐invasive
long‐term and real‐time analysis of endocrine cells on micro‐electrode arrays,
The Journal of physiology, 590 (2012) 1085-1091.
H.C.
Gerstein, J. Bosch, G.R. Dagenais, R. Diaz, H. Jung, A.P. Maggioni, J. Pogue,
J. Probstfield, A. Ramachandran, M.C. Riddle, L.E. Ryden, S. Yusuf, Basal
insulin and cardiovascular and other outcomes in dysglycemia, N Engl J Med, 367
(2012) 319-328.
D.
des Techniques, J. Selam, D. Selam, J. Bringer, B. Catargi, B. Charbonnel, G.
Charpentier, H. Gin, B. Guerci, M. Haardt, INFUSYSTEMES FRANCE. INFUS, J
Diabetes Sci Technol, 4 (2012) 1400-1407.
J.
Bosch, H.C. Gerstein, G.R. Dagenais, R. Diaz, L. Dyal, H. Jung, A.P. Maggiono,
J. Probstfield, A. Ramachandran, M.C. Riddle, L.E. Ryden, S. Yusuf, n-3 fatty
acids and cardiovascular outcomes in patients with dysglycemia, N Engl J Med,
367 (2012) 309-318.
P.-Y.
Benhamou, B. Catargi, B. Delenne, B. Guerci, H. Hanaire, N. Jeandidier, R.
Leroy, L. Meyer, A. Penfornis, R.-P. Radermecker, Real-time continuous glucose
monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of
experts from SFD, EVADIAC and SFE, Diabetes & metabolism, 38 (2012)
S67-S83.
P.
Schaepelynck, E. Renard, N. Jeandidier, H. Hanaire, C. Fermon, S. Rudoni, B.
Catargi, J.-P. Riveline, B. Guerci, L. Millot, A recent survey confirms the
efficacy and the safety of implanted insulin pumps during long-term use in
poorly controlled type 1 diabetes patients, Diabetes technology &
therapeutics, 13 (2011) 657-660.
G.
Charpentier, P.-Y. Benhamou, D. Dardari, A. Clergeot, S. Franc, P.
Schaepelynck-Belicar, B. Catargi, V. Melki, L. Chaillous, A. Farret, The diabeo
software enabling individualized insulin dose adjustments combined with
telemedicine support improves hba1c in poorly controlled type 1 diabetic
patients, Diabetes care, 34 (2011) 533-539.
C.
Ancla, V. Lapeyre, I. Gosse, B. Catargi, V. Ravaine, Designed
glucose-responsive microgels with selective shrinking behavior, Langmuir, 27
(2011) 12693-12701.
A.
Ravaud, C. de la Fouchardière, J. Asselineau, J.-P. Delord, C. Do Cao, P.
Niccoli, P. Rodien, M. Klein, B. Catargi, Efficacy of sunitinib in advanced
medullary thyroid carcinoma: intermediate results of phase II THYSU, The
oncologist, 15 (2010) 212-213.
A.
Ravaud, C. De la Fouchardière, F. Courbon, J. Asselineau, M. Klein, P.
Nicoli-Sire, C. Bournaud, J. Delord, G. Weryha, B. Catargi, Sunitinib in
patients with refractory advanced thyroid cancer: the THYSU phase II trial,
Journal of Clinical Oncology, 26 (2008) 6058-6058.
V.
Ravaine, C. Ancla, B. Catargi, Chemically controlled closed-loop insulin
delivery, Journal of Controlled Release, 132 (2008) 2-11.
V.
Lapeyre, C. Ancla, B. Catargi, V. Ravaine, Glucose-responsive microgels with a
core–shell structure, Journal of colloid and interface science, 327 (2008)
316-323.
N.
Jeandidier, J.-P. Riveline, N. Tubiana-Rufi, A. Vambergue, B. Catargi, V.
Melki, G. Charpentier, B. Guerci, Treatment of diabetes mellitus using an
external insulin pump in clinical practice, Diabetes & metabolism, 34
(2008) 425-438.
A.S.
Cunha, C. Beau, A. Rault, B. Catargi, D. Collet, B. Masson, Laparoscopic versus
open approach for solitary insulinoma, Surgical endoscopy, 21 (2007) 103-108.
A.
Tabarin, Y. Diz-Chaves, M. Carmona, B. Catargi, E. Zorrilla, A. Roberts, D.
Coscina, S. Rousset, A. Redonnet, G. Parker, Resistance to diet-induced obesity
in mu-opioid receptor-deficient mice: evidence for a" thrifty gene".
DIABETES, 55 (2006) 862-862.
A.
Tabarin, Y. Diz-Chaves, M. del Carmen Carmona, B. Catargi, E.P. Zorrilla, A.J.
Roberts, D.V. Coscina, S. Rousset, A. Redonnet, G.C. Parker, Resistance to
Diet-Induced Obesity in μ-Opioid Receptor–Deficient Mice, Diabetes, 54 (2005)
3510-3516.
B.
Gatta, D.H. Hau, B. Catargi, P. Roger, A. Tabarin, Re-evaluation of the
efficacy of the association of cabergoline to somatostatin analogues in
acromegalic patients, Clinical endocrinology, 63 (2005) 477.
Catargi, Current status and future of
implantable insulin pumps for the treatment of diabetes, Expert review of
medical devices, 1 (2004) 181-185.
M.
Ries, F. Basseau, B. Tyndal, R. Jones, C. Deminière, B. Catargi, C. Combe, C.W.
Moonen, N. Grenier, Renal diffusion and BOLD MRI in experimental diabetic
nephropathy, Journal of Magnetic Resonance Imaging, 17 (2003) 104-113.
H.
Gin, E. Renard, V. Melki, S. Boivin, P. Schaepelynck-Belicar, B. Guerci, J.
Selam, J. Brun, J. Riveline, B. Estour, Combined improvements in implantable
pump technology and insulin stability allow safe and effective long term
intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC
experience, Diabetes & metabolism, 29 (2003) 602-607.
B.
Catargi, V. Rigalleau, A. Poussin, N. Ronci-Chaix, V. Bex, V. Vergnot, H. Gin,
P. Roger, A. Tabarin, Occult Cushing’s syndrome in type-2 diabetes, The Journal
of Clinical Endocrinology & Metabolism, 88 (2003) 5808-5813.
B.
Catargi, M. Monsaingeon, V. Bex-Bachellerie, N. Ronci-Chaix, H. Trouette, A.
Margotat, A. Tabarin, P. Beck-Peccoz, A novel thyroid hormone receptor-beta
mutation, not anticipated to occur in resistance to thyroid hormone, causes
variable phenotypes, Hormone Research in Paediatrics, 57 (2002) 137-142.
N.
Valli, B. Catargi, N. Ronci, V. Vergnot, F. Leccia, J. Ferriere, G. Chene, N.
Grenier, F. Laurent, A. Tabarin, Biochemical screening for subclinical
cortisol-secreting adenomas amongst adrenal incidentalomas, European Journal of
Endocrinology, 144 (2001) 401-408.
H.
Gin, V. Melki, B. Guerci, B. Catargi, Clinical evaluation of a newly designed
compliant side port catheter for an insulin implantable pump, Diabetes Care, 24
(2001) 175-175.
B.
Catargi, D. Breilh, H. Gin, V. Rigalleau, M. Saux, P. Roger, A. Tabarin, Etude
comparative du controle glycemique et du risque d'hypoglycemie obtenus par
pompe a insuline non programmable et programmable, Diabetes and Metabolism, 27
(2001) 323-328.
B.
Catargi, D. Breilh, P. Roger, A. Tabarin, Glucose profiles in a type 1 diabetic
patient successively treated with CSII using regular insulin, lispro and an
implantable insulin pump, Diabetes & metabolism, 26 (2000) 210-214.
C.
Bonnin, B. Gatta, B. Fremy, V. Bachellerie, N. Ronci, M. Duclos, M. Grino, B.
Masson, B. Catargi, A. Tabarin, Acromegaly caused by ectopic growth
hormone-releasinghormone secretion, Growth Hormone & IGF Research, 10
(2000) S157.
N.
Valli, B. Catargi, N. Ronci, F. Leccia, M. Guyot, P. Roger, D. Ducassou, A.
Tabarin, Evaluation of indium-111 pentetreotide somatostatin receptor
scintigraphy to detect recurrent thyroid carcinoma in patients with negative
radioiodine scintigraphy, Thyroid, 9 (1999) 583-589.
A.
Tabarin, N. Valli, P. Chanson, Y. Bachelot, V. Rohmer, V. Bex-Bachellerie, B.
Catargi, P. Roger, F. Laurent, Usefulness of somatostatin receptor scintigraphy
in patients with occult ectopic adrenocorticotropin syndrome, The Journal of
Clinical Endocrinology & Metabolism, 84 (1999) 1193-1202.
B.
Catargi, J. Raymond, V. Lafarge-Gense, F. Leccia, P. Roger, A. Tabarin,
Localization of parathyroid tumors using endoscopic ultrasonography in primary
hyperparathyroidism, Journal of endocrinological investigation, 22 (1999)
688-692.
B.
Catargi, F. Parrot-Roulaud, C. Cochet, D. Ducassou, P. Roger, A. Tabarin,
Homocysteine, hypothyroidism, and effect of thyroid hormone replacement,
Thyroid, 9 (1999) 1163-1166.
B.
Catargi, F. Leprat, M. Guyot, N. Valli, D. Ducassou, A. Tabarin, Optimized
radioiodine therapy of Graves' disease: analysis of the delivered dose and of
other possible factors affecting outcome, European journal of endocrinology,
141 (1999) 117-121.
B.
Catargi, E. Felicie-Dellan, A. Tabarin, Comment on gonadotroph adenoma causing
ovarian hyperstimulation, The Journal of Clinical Endocrinology &
Metabolism, 84 (1999) 3404-3404.
A.
Tabarin, F. Laurent, B. Catargi, F. Olivier‐Puel, R. Lescene, J. Berge, F. San
Galli, J. Drouillard, P. Roger, J. Guerin, Comparative evaluation of
conventional and dynamic magnetic resonance imaging of the pituitary gland for
the diagnosis of Cushing's disease, Clinical endocrinology, 49 (1998) 293-300.
H.
Gin, B. Catargi, V. Rigalleau, E. Rullier, P. Roger, A. Tabarin, Experience
with the Biostator for diagnosis and assisted surgery of 21 insulinomas,
European journal of endocrinology, 139 (1998) 371-377.
A.
Tabarin, B. Catargi, P. Chanson, S. Hieronimus, J.B. Corcuff, F. Laurent, M.
Harter, J. Drouillard, P. Roger, Pseudo‐tumours of the thymus after correction
of hypercortisolism in patients with ectopic ACTH syndrome: a report of five
cases, Clinical endocrinology, 42 (1995) 207-213.
PATENTS
R. Auzely-Velty, E. Hachet, B. Catargi, V. Ravaine and
L. Messager; 2017; Glucose responsive hydrogel comprising PBA-grafted
hyaluronic acid (HA); US Patent 9,549,987
J. Lang, B. Catargi, M. Raoux, S. Renaud, G.
Charpentier and Y. Bornat; 2010; Sensor for measuring the activity of
beta-pancreatic cells or of islets of Langerhans, manufacture and use of such a
sensor; WO2011EP50359 20110112; BR20121117440 20110112; 2016/04/19/;
AU2011206641 (A1) AU2011206641
(A8) AU2011206641 (B2) CA2787302 (A1) CN102933143 (A) CN102933143 (B) EP2523595 (A1) FR2955179 (A1) IL220923 (A) JP2013517029 (A) JP5715160 (B2) KR20120120299 (A) MX2012008129 (A) US2013030271 (A1) WO2011086105 (A1)